Cialis Shortage: What Providers and Prescribers Need to Know in 2026

Provider Briefing: Tadalafil (Cialis) Availability in 2026

Your patients are asking about Tadalafil availability — and some are reporting difficulty filling prescriptions at retail pharmacies. This briefing covers what you need to know about the current supply picture, prescribing implications, and tools to help your patients access their medication.

While Tadalafil is not in a formal FDA- or ASHP-listed shortage, localized availability issues are real and recurring. Understanding the dynamics can help you anticipate patient concerns and proactively manage treatment plans.

Timeline: How We Got Here

The Tadalafil supply landscape has evolved significantly:

• 2003: FDA approves Cialis (Tadalafil) for erectile dysfunction
• 2011: FDA expands indication to include BPH and combined ED/BPH
• 2018: Cialis patent expires; generic Tadalafil enters the market with multiple ANDA approvals
• 2020-2023: Telehealth platforms (Hims, Ro, BlueChew) drive significant growth in Tadalafil prescribing volume
• 2024-2026: Demand continues to outpace inventory at some retail pharmacies, particularly for 5 mg and 20 mg strengths, despite adequate manufacturing capacity

The current situation is primarily demand-driven rather than manufacturing-constrained. Multiple generic manufacturers are producing Tadalafil, and aggregate supply appears sufficient — but distribution and pharmacy-level stocking decisions create patient-facing availability gaps.

Prescribing Implications

Strength-Specific Availability

Availability varies by strength. The 5 mg (daily) and 20 mg (as needed) formulations see the highest demand and are most likely to be out of stock at any given pharmacy. The 2.5 mg and 10 mg strengths may be more readily available.

Consider whether a dose adjustment could allow your patient to access an available strength without compromising therapeutic efficacy. For example:

• A patient on daily 5 mg who can't find it may do well on daily 2.5 mg with a follow-up assessment
• Patients using 10 mg as needed may be able to use a 20 mg tablet split in half (with appropriate counseling)

Generic vs. Brand Considerations

Brand Cialis remains available but at a significant cost premium ($400-$960 for 30 tablets). For most patients, generic Tadalafil is therapeutically equivalent and dramatically more affordable. There is no clinical reason to prefer brand over generic unless a patient reports a specific tolerability concern with a particular generic manufacturer's formulation.

Insurance and Prior Authorization

Be aware that many commercial plans and Medicare Part D plans either exclude ED medications or impose significant restrictions:

• Quantity limits: Typically 6-12 tablets per month for as-needed dosing
• Prior authorization: Often required, especially for brand Cialis
• Step therapy: Some plans require a trial of Sildenafil before approving Tadalafil
• BPH indication: Daily Tadalafil 5 mg prescribed for BPH may have more favorable coverage than the same drug prescribed for ED

When clinically appropriate, documenting the BPH indication in the prescription can improve coverage chances for patients who have both conditions.

Current Availability Picture

Based on pharmacy-level data and patient reports in early 2026:

• Large chain pharmacies (CVS, Walgreens, Rite Aid): Intermittent stock-outs, especially for 5 mg and 20 mg. Automated ordering systems may under-stock based on historical dispensing patterns.
• Independent pharmacies: Generally more reliable access due to flexible wholesaler relationships and ability to special-order.
• Mail-order pharmacies: Amazon Pharmacy, Cost Plus Drugs, and specialty mail-order services report consistent availability.
• Telehealth-integrated pharmacies: Hims, Ro, and similar platforms maintain dedicated supply chains and report minimal stock issues.

Cost and Access Dynamics

The cost barrier is as significant as the availability barrier for many patients:

• Generic Tadalafil with discount coupon: $0.20-$2.00 per tablet
• Generic Tadalafil at retail (no coupon): $8-$12 per tablet
• Brand Cialis: $13-$32 per tablet
• Cost Plus Drugs (mail order): Approximately $0.10-$0.30 per tablet

Patients who are uninsured or underinsured should be directed to discount coupon programs (GoodRx, SingleCare, RxSaver) or patient assistance programs. The Lilly Cares Foundation provides brand Cialis at no cost to qualifying low-income patients. For comprehensive cost guidance, see our patient resource: How to Save Money on Cialis in 2026.

Tools and Resources for Your Practice

Medfinder for Providers

Medfinder for Providers helps you and your staff check real-time pharmacy availability for Tadalafil and other medications. You can verify stock before sending a prescription, reducing patient callbacks and failed fill attempts.

Alternative Prescribing Options

When Tadalafil is unavailable, consider these therapeutic alternatives:

• Sildenafil (Viagra): Most widely available and affordable PDE5 inhibitor. 25-100 mg as needed. Generic readily available at virtually all pharmacies.
• Vardenafil (Levitra): More PDE5-selective, may produce fewer side effects in some patients. 5-20 mg as needed. Generic available.
• Avanafil (Stendra): Fastest onset (15 minutes), good option for patients who value spontaneity but don't need 36-hour duration. 50-200 mg as needed. Higher cost.

For a detailed clinical comparison, see our provider's guide to helping patients find Cialis.

Patient Communication

Proactively discussing availability with your patients can reduce frustration and improve adherence:

• Inform patients that Tadalafil is not in a formal shortage but localized stock-outs occur
• Recommend patients refill 5-7 days before running out
• Suggest trying independent pharmacies or mail-order services
• Provide the Medfinder link as a resource for finding medications in stock

Looking Ahead

The Tadalafil supply situation is expected to gradually stabilize as additional generic manufacturers increase production capacity and distribution networks adjust to the sustained demand from telehealth prescribing. However, localized availability issues will likely persist through 2026.

Staying informed about the supply picture and having a backup prescribing plan will help you maintain continuity of care for your patients. For ongoing updates, visit Medfinder for Providers.

Final Thoughts

Tadalafil availability in 2026 is a distribution and demand challenge, not a manufacturing crisis. By understanding the dynamics, using available tools, and communicating proactively with patients, you can help ensure your patients maintain access to their medication — or transition smoothly to an appropriate alternative when needed.

Related resources for your patients:

• Why Is Cialis So Hard to Find?
• How to Find Cialis in Stock Near You
• Alternatives to Cialis